Lupahakemukset
Lupahakemukset
Lupahakemukset
The application for authorisation process includes a period of consultation. It lasts for eight weeks.
Provide your comments
In order to facilitate the work of ECHA's Committees in reviewing the comments received, you are kindly invited to provide your comments in English preferably. By clicking on a link in the table below, you will get access to the full broad information on the use applied for, and to the related commenting form. Comments are welcomed from the EU or beyond.
Consultations close at 23:59 Helsinki time (EET).
Adopted opinions and previous consultations on applications for authorisation
There are currently no ongoing consultations.
| 0236-01 | Initial | Sodium dichromate | 234-190-3 |
7789-12-0 10588-01-9 |
13/10/2021 | Robur S.p.A | Use of sodium dichromate as an anticorrosion agent of the carbon steel in sealed circuit of gas absorption appliances up to 1.05% w/w (corresponding to 0.42% w/w as Cr VI) in the refrigerant solution | |
| 0237-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | 13/10/2021 | Carlo Nobili SPA Rubinetterie | Use at industrial site electroplating of different types of substrates to achieve functional surfaces with high durability and a bright or matt silvery appearance for sanitary applications | |
| 0238-01 | initial | Chromium trioxide | 215-607-8 | 1333-82-0 | 13/10/2021 | Hueck-Engraving GmbH & Co.KG | Functional chrome plating of high-quality stainless-steel press plates for the premium wood-based materials industry | |
| 0239-01 | initial | 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated | - | - | 13/10/2021 | Prionics Lelystad B.V | Use as component of buffer solutions to produce antigens (Cell extraction, cell lysis, coating of biological antigens onto articles, inactivation of microorganisms that produce targeted antigen and solvent exchange) and in-process and final Quality Control of antigens intended for use as veterinary and human health laboratory reagents in Scientific Research and Development and In Vitro Diagnostic applications | |
| 0239-02 | Initial | 4-Nonylphenol, branched and linear, ethoxylated | - | - | 13/10/2021 | Prionics Lelystad B.V. | Use as component of buffer solutions to produce antigens (Cell extraction, cell lysis, coating of biological antigens onto articles, inactivation of microorganisms that produce targeted antigen and solvent exchange) and in-process and final Quality Control of antigens intended for use as veterinary and human health laboratory reagents in Scientific Research and Development and In Vitro Diagnostic applications | |
| 0240-01 | Initial | 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated | - | - | 13/10/2021 | Alexion Pharma International Operations Unlimited Company | Industrial use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated for virus inactivation in the manufacture Andexanet alfa for treatment of adult patients treated with a direct factor Xa (FXa) inhibitor when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding | |
| 0241-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | 13/10/2021 |
Gessi S.p.A. San Marco Rubinetteria S.r.l. |
Use of chromium trioxide for electroplating of metal substrates with the purpose of creating a long-lasting high durability surface with bright look for kitchen and bathroom sanitaryware (functional plating with decorative character) | |
Related links
- Authorisation list
- Applications for authorisation Regulations
- Applying for authorisation Support
- Applications for authorisation Addressing Chemicals of Concern
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.